Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
117.4 USD | +0.63% | -7.59% | -15.66% |
Apr. 16 | ANALYST RECOMMENDATIONS : AMD, Colgate, Fair Isaac, Tyson Foods, AstraZeneca | |
Apr. 16 | Baptista Research Downgrades Illumina to Hold From Buy, Adjusts PT to $149.60 From $145 | MT |
Financials (USD)
Sales 2024 * | 4.52B | Sales 2025 * | 4.96B | Capitalization | 18.7B |
---|---|---|---|---|---|
Net income 2024 * | -114M | Net income 2025 * | 271M | EV / Sales 2024 * | 4.15 x |
Net Debt 2024 * | 23.8M | Net cash position 2025 * | 770M | EV / Sales 2025 * | 3.61 x |
P/E ratio 2024 * |
-197
x | P/E ratio 2025 * |
60.5
x | Employees | 10,615 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.73% |
Latest transcript on Illumina, Inc.
1 day | +0.63% | ||
1 week | -7.59% | ||
Current month | -14.48% | ||
1 month | -11.81% | ||
3 months | -13.58% | ||
6 months | -2.13% | ||
Current year | -15.66% |
Managers | Title | Age | Since |
---|---|---|---|
Jacob Thaysen
CEO | Chief Executive Officer | 49 | 23-09-24 |
Steven Barnard
CTO | Chief Tech/Sci/R&D Officer | - | 97-12-31 |
Carissa Rollins
CTO | Chief Tech/Sci/R&D Officer | 54 | 22-03-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Epstein
BRD | Director/Board Member | 69 | 12-11-28 |
Chairman | 60 | 23-06-01 | |
Caroline Dorsa
BRD | Director/Board Member | 64 | 17-01-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.11% | 2 M€ | -.--% | ||
3.62% | 1 M€ | 0.00% | - | |
3.11% | 0 M€ | 0.00% | - | |
3.03% | 0 M€ | 0.00% | - | |
1.77% | 2 M€ | -25.75% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 117.4 | +0.63% | 1,418,214 |
24-04-18 | 116.7 | -1.35% | 1,810,342 |
24-04-17 | 118.3 | +0.51% | 1,866,302 |
24-04-16 | 117.7 | -2.86% | 1,698,207 |
24-04-15 | 121.2 | -4.65% | 1,616,891 |
Delayed Quote Nasdaq, April 19, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.66% | 18.7B | |
+2.64% | 208B | |
+1.80% | 174B | |
+8.59% | 130B | |
+16.47% | 98.97B | |
-3.42% | 60.46B | |
+12.71% | 51.73B | |
-6.61% | 45.33B | |
-4.53% | 38.9B | |
+9.27% | 38.56B |
- Stock Market
- Equities
- ILMN Stock